The influence of a vasopressin-analogue (DGAVP) on event-related potentials in a stimulus-mismatch paradigm.
To assess the influence of DGAVP (des-glycinamide-arginine-8-vasopressin, a synthetic vasopressin analogue) on the processing of stimuli and stimulus deviance in humans in a double-blind cross-over experiment, 13 subjects received 60 IU DGAVP versus placebo intranasally 48, 24, and 1 h prior to the experimental session. Auditory event-related potentials (ERPs) were taken as a tool to investigate central nervous processing in an experimental task that required the subjects to count different kinds of rare tone pips deviating in pitch and probability compared to frequent standard tones. Direction of attention was manipulated by instructing the subject to count a different class of deviating tone pips in each attention condition. DGAVP enhanced the N2 of the ERP to tone pips deviating extremely in pitch from standard tones, whether or not the extremely deviating pips were to be attended to by the subjects. This influence suggests an intensified mismatch processing under DGAVP that may result from a general excitatory effect of this substance on cortical activity.
Pietrowsky
R
R
Angewandte Physiologie, Innere Medizin I, Universität Ulm, F.R.G.
Born
J
J
Fehm-Wolfsdorf
G
G
Fehm
H L
HL
D000281:Administration, Intranasal; D000328:Adult; D001127:Arginine Vasopressin / Q000494:pharmacology / Q000031:analogs & derivatives; D001143:Arousal / Q000187:drug effects*; D001288:Attention / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004569:Electroencephalography; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D006801:Humans; D008297:Male; D010897:Pitch Discrimination / Q000187:drug effects*
D001127:Arginine Vasopressin; C015119:argipressin, des-GlyNH2(9)-